Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,668 signal articles · 38 in last 24h · 156,009 total before filter · latest 1h ago
38last 24h
849last 7d
149● bullish (7d)
87● bearish (7d)
214publishers
AllMacro187Earnings111M&A123Regulatory19Product19Analyst21
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Hewlett Packard Enterprise (HPE) Wins Top Zacks Rank, Is It Still Undervalued?
Simply Wall St.8d agobullish
Hewlett Packard Enterprise (HPE) Wins Top Zacks Rank, Is It Still Undervalued?

Hewlett Packard Enterprise (HPE) has drawn fresh attention after outperforming its Computer and Technology sector peers this year, as analysts raised earnings estimates and assigned the stock a top Zacks Rank rating. Recent trading has cooled slightly, with the share price down over the past week, although Hewlett Packard Enterprise still carries a 30-day share price return of 14.36% and a 90-day gain of 28.16% at a latest share price of $60.76. That short term momentum sits on top of a...

Centrus Energy (LEU) Signs Two HALEU Supply Agreements Backing Reactor And Security Demand
Simply Wall St.8d agoneutral
Centrus Energy (LEU) Signs Two HALEU Supply Agreements Backing Reactor And Security Demand

Centrus Energy (NYSE:LEU) agreed to a multi year HALEU supply contract with Antares Nuclear to fuel advanced reactor projects. The company also signed an agreement with Radiant that links its HALEU output to advanced reactors and national security uses. Both arrangements include prepayments intended to expand Centrus Energy's domestic high assay low enriched uranium production capacity. The new Antares and Radiant HALEU deals change the story, but they should not be your only focus. Check...

3 US Stocks Tied To Onshoring That Investors May Want To Watch
Simply Wall St.8d agoneutral
3 US Stocks Tied To Onshoring That Investors May Want To Watch

Trade disputes, tech regulations and shifting rules on critical exports are pulling global supply chains in new directions, turning onshoring from a buzzword into a real capital spending theme. That creates a window for investors who want exposure to solid manufacturers linked to domestic production rather than far flung networks. This article examines three large cap stocks connected to these developments and outlines key reasons each one may warrant closer review at this time. The three...

Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative
Simply Wall St.8d agoneutral
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative

Earlier this month, Tempus AI announced a multi‑year initiative to build a research platform of 100,000 whole genomes linked to longitudinal clinical, imaging, pathology and outcome data, with plans to eventually scale toward one million genomes and offer broad access via its Tempus Lens environment by mid‑2027. This move extends Tempus AI beyond targeted panels into whole‑genome sequencing, creating a model‑ready, multimodal dataset specifically tailored for AI‑driven disease and drug...

Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?
Simply Wall St.8d agoneutral
Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?

In recent commentary, Novanta (NASDAQ:NOVT) has been highlighted for its multi-year annual revenue growth of 10.7% and a gross margin of 44.4%, reflecting perceived market share gains and strong product positioning. This attention centers on Novanta’s combination of demand acceleration expectations and high-margin products, which analysts view as evidence of superior competitive capabilities. Next, we will examine how this focus on Novanta’s revenue momentum and margins may influence the...

Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress
Simply Wall St.8d agoneutral
Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress

The analyst fair value estimate for Iovance Biotherapeutics has shifted from US$9.33 to US$10.00 per share, reflecting a fresh round of updated models. Recent research points to Amtagvi revenue trends, margin progression, and the potential impact of upcoming data such as IOV-LUN-202 as key reasons behind the new cluster of price targets in the US$10 to US$15 range. Read on to see how these moves fit into the broader analyst narrative and how to track the next set of updates. Analyst Price...

How Dow’s AI-Driven Efficiency Push and SupraCare Expansion At Dow (DOW) Has Changed Its Investment Story
Simply Wall St.8d agoneutral
How Dow’s AI-Driven Efficiency Push and SupraCare Expansion At Dow (DOW) Has Changed Its Investment Story

Earlier this month, Univar Solutions USA LLC announced an expanded agreement to distribute Dow’s SupraCare™ polymers and specialty additives for homecare and industrial cleaning formulators across the US and Canada, while Dow also outlined progress on its Transform to Outperform efficiency program. This combination of broader market access for high-performance cleaning ingredients and a technology-driven cost-saving plan underscores how Dow is pairing product innovation with operational...

What SoFi Technologies (SOFI)'s Record Q2 2026 Cross-Buy Momentum Means For Shareholders
Simply Wall St.8d agobullish
What SoFi Technologies (SOFI)'s Record Q2 2026 Cross-Buy Momentum Means For Shareholders

In recent months, SoFi Technologies reported record Q2 2026 performance, including loan originations growing 69% year over year, stronger member and product growth, and an expanding mix of fee-based revenues, while operating under a bank charter that lets it fund loans with its own deposits. A key insight from this period is that over half of new products were opened by existing members, suggesting deepening engagement that may enhance SoFi’s ability to diversify revenue across its expanding...

Walmart (WMT) Debuts Predictive Precision Targeting At Sam's Club
Simply Wall St.8d agoneutral
Walmart (WMT) Debuts Predictive Precision Targeting At Sam's Club

Walmart (NasdaqGS:WMT) unit Sam's Club has introduced Predictive Precision Targeting to support first party data-driven advertising for brands. The new Sam's Club capability is pitched as offering measurable performance insights for advertisers using member shopping and engagement data. Walmart and several large retailers are facing scrutiny in 2026 for scaling back diversity, equity, and inclusion initiatives across their operations. The rollout of Predictive Precision Targeting at Sam's...

Marvell (MRVL) and GlobalFoundries (GFS) Rise on Expanded Deal: What Investors Should Know
Insider Monkey8d agoneutral
Marvell (MRVL) and GlobalFoundries (GFS) Rise on Expanded Deal: What Investors Should Know

On September 17, shares of Marvell Technology, Inc. (NASDAQ:MRVL) and GLOBALFOUNDRIES Inc. (NASDAQ:GFS) moved sharply higher, with Marvell Technology, Inc. (NASDAQ:MRVL) gaining more than 4% and GLOBALFOUNDRIES Inc. (NASDAQ:GFS) rising more than 6% by the end of the trading session. Reuters reported that the two companies have expanded their agreement to increase production capacity for […]

Netflix (NFLX) Gets a Bullish $110 Target: What’s Driving the Outlook?
Insider Monkey8d agoneutral
Netflix (NFLX) Gets a Bullish $110 Target: What’s Driving the Outlook?

On September 14, Evercore ISI raised its price target for Netflix, Inc. (NASDAQ:NFLX) from $100 to $110 while maintaining its Outperform rating. The research firm rolled its valuation framework forward to 2028 and applied a multiple of 25 times its 2028 EPS estimate. The new price target represents more than 40% upside from the share […]

Ross Stores (ROST), What Is Behind The Fresh Attention Now?
Simply Wall St.8d agoneutral
Ross Stores (ROST), What Is Behind The Fresh Attention Now?

Ross Stores (ROST) recently refreshed its board, adding technology executive Shelley H. Bransten and consumer investor Christian B. Johnson, while long-serving director Sharon D. Garrett prepares to retire after more than two decades of service. The Ross Stores share price has eased over the past month, with a 1-month share price return of 3.44% and a 7-day share price return of 1.79% lower. At the same time, the stock shows stronger momentum over longer periods, including a 24.01%...

Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales?
Simply Wall St.8d agoneutral
Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales?

Iovance Biotherapeutics has seen its stock price move sharply in recent years, which puts fresh attention on whether the current valuation lines up with the scale of its sales. For anyone looking at Iovance today, the key issue is how that share price stacks up against the revenue base supporting it. The stock has returned 400.0% over the past year, which raises a direct question about how much sales performance can underpin that kind of move. The business model, focused on developing and...

Citi Forecasts Widening Memory Chip Shortages Through 2031 as AI Demand Expands
InvestorsHub8d agoneutral
Citi Forecasts Widening Memory Chip Shortages Through 2031 as AI Demand Expands

Citi expects shortages across the global memory semiconductor market to deepen through 2031, driven by increasing demand for high-bandwidth memory (HBM), DRAM and NAND as artificial intelligence systems adopt continual learning. In a research note published Monday, the investment bank identified continual learning as a potential central theme in AI development over the next five years.